OvaCis® Rapid Test is an in vitro diagnostic (IVD) medical device used intraoperatively to discriminate benign from malignant ovarian cysts. Using immunochromatographic assay, this adjunctive test
OvAi is a CE marked software device, cloud based, usable from any device. It receives the sonography video and uses AI to extract relevant morphological features, which allow to start the diagnostic
Kaivogen’s product portfolio includes unique glycovariant immunoassays for the early and timely diagnostics of cancer. Our assay technology is based on nanoparticles coated with binders,
Yashraj Biotech is a leading manufacturer of native human cancer biomarkers (purified proteins) like: Breast Cancer Antigen (CA 15-3), Gastrointestinal Cancer Antigen (CA 19-9),
sequencing (NGS) method, which analyzes genomic DNA derived from blood or FFPE tissue. For breast and ovarian cancer patients For HBOC (Hereditary breast...and ovarian cancer syndrome) patients For family history or the age of breast cancer incidence
Diagnosing of cancers(liver, testicles, ovaries) & monitoring therapeutic effect High levels of AFP in adults may indicate the possibility...to help diagnose or rule out related abnormalities. Diagnosis diseases Liver cancer, Viral hepatitis, Ovarian cancer, testicular cancer ...of the liver, the ovaries, or the testicles, as well as noncancerous liver diseases such as cirrhosis and hepatitis. The AFP plus measures the level of AFP
in peripheral blood samples from ovarian cancer and breast cancer patients.
breast, skin brain, gastric, ovarian cancers, etc.
and are currently developing our first proprietary IVD test for ovarian cancer diagnostics. All immunoassay components and services can be manufactured according
production by ovaries) | · Decreased risk of ovarian cancer ·
The company launched NGS-based hereditary breast / ovarian cancer panel (BRCAaccuTest™) with clinical analysis S/W (NGeneAnalysis™) and received CE-IVD mark